1-2 of 2
Amanda N. Farrugia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

Andrew C.W. Zannettino, Amanda N. Farrugia, Angela Kortesidis, Jim Manavis, L. Bik To, Sally K. Martin, Peter Diamond, Hirokazu Tamamura, Tsvee Lapidot, Nobutaka Fujii, Stan Gronthos
Journal: Cancer Research
Cancer Res (2005) 65 (5): 1700–1709.
https://doi.org/10.1158/0008-5472.CAN-04-1687
Published: 07 March 2005
View article titled, Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients
Open the PDF for Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients in another window
Journal Articles

Receptor Activator of Nuclear Factor-κB Ligand Expression by Human Myeloma Cells Mediates Osteoclast Formation in Vitro and Correlates with Bone Destruction in Vivo

Amanda N. Farrugia, Gerald J. Atkins, L. Bik To, Beiqing Pan, Noemi Horvath, Panagiota Kostakis, David M. Findlay, Peter Bardy, Andrew C. W. Zannettino
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5438–5445.
Published: 18 September 2003
View article titled, Receptor Activator of Nuclear Factor-κB Ligand Expression by Human Myeloma Cells Mediates Osteoclast Formation <em>in Vitro</em> and Correlates with Bone Destruction <em>in Vivo</em>
Open the PDF for Receptor Activator of Nuclear Factor-κB Ligand Expression by Human Myeloma Cells Mediates Osteoclast Formation <em>in Vitro</em> and Correlates with Bone Destruction <em>in Vivo</em> in another window